Stage 4 Prostate Cancer | BlogEsaurus.com
Links shared publicly online about this topic.
- 1,348total visits
Stage 4 Prostate Cancer | BlogEsaurus.com
View full resource at blogesaurus.com
Tags: Gland, Cancer, Prostate Cancer, Prostate, Men's Health
Most Recently Shared on February 28, 2010 at 9:13 pm By:
Stage 4 Prostate Cancer | BlogEsaurus.com http://bit.ly/av1Uvo
Is a limited lymph node dissection an adequate staging procedure for prostate cancer? - Topix
topix.com — “Is a limited lymph node dissection an adequate staging procedure for prostate cancer? - Topix” View full resource at topix.com
Most Recently Shared on April 7, 2012 at 5:59 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Is a limited lymph node dissection an adequate staging procedure for prostate cancer?: Generally lymph node diss... http://t.co/rmcO4tr1
A Watch-and-Wait Treatment for Prostate Cancer - NYTimes.com
nytimes.com — “A doctor has proposed the least invasive approach for most men with early-stage cancers that are not particularly aggressive.” View full resource at nytimes.com
Most Recently Shared on November 18, 2011 at 2:25 pm By:
Soligenix third quarter revenues increase to $5,796,000
news-medical.net — “Soligenix, Inc., a development stage biopharmaceutical company, announced today its financial results for the third quarter of 2011.” View full resource at news-medical.net
Most Recently Shared on November 14, 2011 at 2:12 pm By:
Cancer News Soligenix third quarter revenues increase to $5,796,000: Soligenix, Inc., a development stage biopha... http://t.co/gG3Zg4aD
FDA: 35 innovative new drugs approved in fiscal year 2011
fda.gov — “Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines. This is among the highest number of approvals in the past decade, surpassed only by 2009 (37). Many of the drugs are important advances for patients, including: two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.” View full resource at fda.gov
Most Recently Shared on November 3, 2011 at 4:08 pm By:
eyeonfda Pharma and Health Lawyer
Press release from #FDA - 35 innovative new drugs approved in fiscal year 2011 http://t.co/lTiE2Z4D
Your HIFU Treatment | Dr. Stephen Scionti - HIFU Specialist
drscionti.com — “Sonablate® HIFU may be effective for men who have early stage, localized prostate cancer that has not spread or metastasized outside the prostate. I will be happy to discuss your individual medical records and history in order to confirm whether or not you are a candidate for Sonablate® HIFU.” View full resource at drscionti.com
Most Recently Shared on October 12, 2011 at 10:33 pm By:
Stephen Scionti, MD Doctor, Surgeon, Urologist, and Physician
Find out if you are a candidate for HIFU with the Sonablate® 500 by going to http://t.co/bXw24z4T
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer - Topix
topix.com — “Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer - Topix” View full resource at topix.com
Most Recently Shared on August 30, 2011 at 6:47 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer: Accuray Incorporated , the premier radiat... http://t.co/q4NJsAV
Prostate Cancer Prevented by Supplements, Lifestyle Changes
herbalmd.com — “Prostate cancer is one of the most commons causes of death among men, however it may be prevented or treated successfully when detected in the early stages.” View full resource at herbalmd.com
Most Recently Shared on August 26, 2011 at 1:05 pm By:
Ray Mcnamee CAM and Health Communicator
Prostate Cancer http://t.co/mvJ2JTB
Soligenix second quarter revenues decrease to $406,000
news-medical.net — “Soligenix, Inc., a late-stage biopharmaceutical company, announced today its financial results for the second quarter of 2011.” View full resource at news-medical.net
Most Recently Shared on August 12, 2011 at 5:20 pm By:
Prostate Cancer: Soligenix second quarter revenues decrease to $406,000: Soligenix, Inc., a late-stage biopharma... http://t.co/M5EtXt4
About how long can the average person live with stage 4 colon cancer? | Prostate Cancer Blog
prostatecancercommunity.com — “I know someone who just found out they had colon cancer and i know it is a deadly disease i just don't know how deadly. Noone can accurately predict how long” View full resource at prostatecancercommunity.com
Most Recently Shared on August 6, 2011 at 1:28 pm By:
About how long can the average person live with stage 4 colon cancer? http://bit.ly/qc40cT
Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe
news-medical.net — “Soligenix, Inc., a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc. for the development and commercialization of orBec into the European territory.” View full resource at news-medical.net
Most Recently Shared on July 29, 2011 at 5:26 am By:
Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe: Soligenix, Inc., a late-st... http://bit.ly/o4OwcM
Scientists discover DNA regions influencing prostate cancer risk | Science News SciGuru.com
sciguru.com — “With the seven newly discovered single nucleotide polymorphisms, scientists are now able to explain about 25% of familial cancer risk. The exact DNA variants that contribute to prostate cancer risk have now been published by an international research consortium with participation of scientists from the German Cancer Research Center. In a multi-stage study, the collaborators systematically searched the whole genome of cancer patients and healthy controls for specific gene variants. Then they calc” View full resource at sciguru.com
Most Recently Shared on July 17, 2011 at 10:25 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Scientists discover DNA regions influencing prostate cancer risk (Science News and Information from SciGuru.com)... http://bit.ly/n24R4y
A weapon against prostate cancer - Topix
topix.com — “A weapon against prostate cancer - Topix” View full resource at topix.com
Most Recently Shared on June 12, 2011 at 10:30 am By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
A weapon against prostate cancer: Thirteen years ago, Lino Pasqualone of Mahopac was diagnosed with stage 4 pros... http://bit.ly/mLNfJv
Exelixis shares slide as CEO cheers a mid-stage prostate cancer success - FierceBiotech
fiercebiotech.com — “Not long after Mike Morrissey took the helm at Exelixis ($EXEL) in the summer of 2010 he decided to restructure and go all in on cabozantinib, the biotech's promising cancer drug that had already Read more...” View full resource at fiercebiotech.com
Most Recently Shared on June 7, 2011 at 12:26 pm By:
John Carroll Health Communicator
Exelixis shares slide as CEO cheers Ph2 prostate cancer success http://bit.ly/iNxT4s
Study Shows Benefit of J&J Prostate Cancer Drug Zytiga - WSJ.com
online.wsj.com — “Johnson & Johnson's prostate cancer drug Zytiga showed a slightly improved survival benefit in updated data from a late-stage study that also revealed the potential for a new way to measure the common disease.” View full resource at online.wsj.com
Most Recently Shared on June 4, 2011 at 10:14 pm By:
Study Shows Benefit of Zytiga http://on.wsj.com/mPK4Yt
Robotic Prostatectomy Expert Dr. David Samadi On A High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment
medicalnewstoday.com — “A new prostate cancer study published in the New England Journal of Medicine comparing surgical treatment to watchful waiting revealed important findings for patients newly diagnosed with prosta” View full resource at medicalnewstoday.com
Most Recently Shared on May 27, 2011 at 12:06 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
Robotic Prostatectomy Expert Dr. David Samadi On A High Impact Study Advocating Aggressive Early-Stage Prostate ... http://bit.ly/iGT9Y4
Advertisement
